Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2020/11/029248
CTRI/2020/11/029248
Not yet recruiting
Phase 2

A randomized controlled clinical trial of efficacy of Virechan karma on Insulin Resistance with Special Reference to Santarpanjanya Vikar(Medorog) - RCVKIR

Vidya Boinwad0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Vidya Boinwad
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Vidya Boinwad

Eligibility Criteria

Inclusion Criteria

  • •HOMA IR \> 2
  • •BMI \>23 to 27\.9

Exclusion Criteria

  • •Patient who are not willing for treatment
  • •Patient in critical condition
  • •Pregnant women
  • •Virechan ayogya

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 2
Efficacy of apamarga kshar internally in the management of hyperlipidemiaHealth Condition 1: E669- Obesity, unspecified
CTRI/2023/05/052998Shraddha Siddheshwar Mule
Not yet recruiting
Phase 3
A randomized controlled clinical trial on effect of topical clotrimazole vs. topical fluconazole vs. topical application of gentian violet in the treatment of otomycosis conducted in a tertiary health care centre
CTRI/2024/05/067969K J Somaiya Medical College and Hospital
Not yet recruiting
Phase 2
Efficacy of Navaka Kashaya and Manjisthadi Tail in the management of dry eczema.Health Condition 1: L209- Atopic dermatitis, unspecified
CTRI/2023/07/054863ATIONAL INSTITUTE OF AYURVEDA DEEMED TO BE UNIVERSITY
Not yet recruiting
Phase 2
A clinical trial to study the efficacy of intravenous albumin infusion along with corticosteroids and nutrition in patients with Acute Severe Ulcerative ColitisHealth Condition 1: K50-K52- Noninfective enteritis and colitis
CTRI/2020/12/029656AIIMS
Active, not recruiting
Not Applicable
Treatment of second degree burns with Flaminal® versus Flammazine®Patients with partial thickness burns and/ or mixed depth of partial and full thickness burnsMedDRA version: 14.1Level: LLTClassification code 10015723Term: Extensive burnsSystem Organ Class: 100000004863MedDRA version: 14.1Level: LLTClassification code 10006796Term: Burns eyesSystem Organ Class: 100000004863MedDRA version: 14.1Level: LLTClassification code 10006795Term: Burns extensiveSystem Organ Class: 100000004863MedDRA version: 16.0Level: LLTClassification code 10006794Term: Burns classified according to extent of body surface involvedSystem Organ Class: 100000004863MedDRA version: 14.1Level: LLTClassification code 10043441Term: Third degree burnsSystem Organ Class: 100000004863MedDRA version: 14.1Level: LLTClassification code 10006801Term: Burns of multiple specified sites, unspecified degreeSystem Organ Class: 100000004863MedDRA version: 16.0Level: LLTClassification code 10012087Term: Deep necrosis of underlying tissues due to burns (dtd) of multiple specified sites w/o mention lobpSystem Organ Class: 100000004863MedDRA version: 14.1Level: LLTClassification code 10028175Term: Multiple burnsSystem Organ Class: 100000004863MedDRA version: 14.1Level: LLTClassification code 10039798Term: Second degree burnsSystem Organ Class: 100000004863MedDRA version: 16.0Level: LLTClassification code 10031700Term: Other burns of eyelids and periocular areaSystem Organ Class: 100000004863Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
EUCTR2013-000901-21-NLRode Kruis Ziekenhuis